QUALAS Validation in Dutch

Key facts

Sponsor

Erasmus Medical Center

Principal Investigator

Lisette 't Hoen, MD, PhD

Erasmus Medical Center

Intervention

QUALAS survey(other)

Enrollment

300 enrolled

Eligibility

8 years · All sexes

Timeline

2024 – 2025

Study locations (2)

• UMCG, Groningen, Netherlands
• Erasmus MC, Rotterdam, Netherlands

Collaborators

University Medical Center Groningen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for OBSOLETE: Total spina bifida cystica

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06025734
  Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
  University of Texas Southwestern Medical Center
• RECRUITINGNANCT06918119
  Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
  Mayo Clinic
• RECRUITINGNANCT06929572
  Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
  The University of Texas Health Science Center, Houston
• ACTIVE NOT RECRUITINGNCT07048691
  Prenatal and Postnatal Ultrasonographic Evaluation of Myelomeningocele to Predict Post-Surgical Outcomes
  Superior University
• RECRUITINGNANCT06796972
  In Utero Surgery for Fetal Myelomeningocele: Decision-making Mechanisms and Psychological Impact of Prenatal Therapy
  Assistance Publique - Hôpitaux de Paris
• RECRUITINGNANCT07178873
  Psychosocial Teleassistance Programme for Adults With Spina Bifida
  University of Deusto
• RECRUITINGNANCT06041334
  Evaluation of muLtimodal and Non-invasive SPINa Bifida Neurovessels During Prospective Follow-up
  Rennes University Hospital
• ACTIVE NOT RECRUITINGNCT07465055
  Operating Room Extubation and Postoperative Outcomes in Neonates With Meningomyelocele
  Gaziantep City Hospital

See all trials for OBSOLETE: Total spina bifida cystica →